263 related articles for article (PubMed ID: 23604552)
1. Fractalkine and its receptor mediate extracellular matrix accumulation in diabetic nephropathy in mice.
Song KH; Park J; Park JH; Natarajan R; Ha H
Diabetologia; 2013 Jul; 56(7):1661-9. PubMed ID: 23604552
[TBL] [Abstract][Full Text] [Related]
2. Reduced inflammatory and neuropathic pain and decreased spinal microglial response in fractalkine receptor (CX3CR1) knockout mice.
Staniland AA; Clark AK; Wodarski R; Sasso O; Maione F; D'Acquisto F; Malcangio M
J Neurochem; 2010 Aug; 114(4):1143-57. PubMed ID: 20524966
[TBL] [Abstract][Full Text] [Related]
3. Fractalkine/CX3CR1 axis modulated the development of pancreatic ductal adenocarcinoma via JAK/STAT signaling pathway.
Huang L; Ma B; Ma J; Wang F
Biochem Biophys Res Commun; 2017 Dec; 493(4):1510-1517. PubMed ID: 28986258
[TBL] [Abstract][Full Text] [Related]
4. Activation of fractalkine/CX3CR1 by vascular endothelial cells induces angiogenesis through VEGF-A/KDR and reverses hindlimb ischaemia.
Ryu J; Lee CW; Hong KH; Shin JA; Lim SH; Park CS; Shim J; Nam KB; Choi KJ; Kim YH; Han KH
Cardiovasc Res; 2008 May; 78(2):333-40. PubMed ID: 18006432
[TBL] [Abstract][Full Text] [Related]
5. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
6. The fractalkine/CX3CR1 system regulates β cell function and insulin secretion.
Lee YS; Morinaga H; Kim JJ; Lagakos W; Taylor S; Keshwani M; Perkins G; Dong H; Kayali AG; Sweet IR; Olefsky J
Cell; 2013 Apr; 153(2):413-25. PubMed ID: 23582329
[TBL] [Abstract][Full Text] [Related]
7. Fractalkine upregulates intercellular adhesion molecule-1 in endothelial cells through CX3CR1 and the Jak Stat5 pathway.
Yang XP; Mattagajasingh S; Su S; Chen G; Cai Z; Fox-Talbot K; Irani K; Becker LC
Circ Res; 2007 Nov; 101(10):1001-8. PubMed ID: 17885215
[TBL] [Abstract][Full Text] [Related]
8. Fractalkine and CX3CR1 mediate leukocyte capture by endothelium in response to Shiga toxin.
Zanchi C; Zoja C; Morigi M; Valsecchi F; Liu XY; Rottoli D; Locatelli M; Buelli S; Pezzotta A; Mapelli P; Geelen J; Remuzzi G; Hawiger J
J Immunol; 2008 Jul; 181(2):1460-9. PubMed ID: 18606701
[TBL] [Abstract][Full Text] [Related]
9. Fractalkine upregulates inflammation through CX3CR1 and the Jak-Stat pathway in severe acute pancreatitis rat model.
Huang LY; Chen P; Xu LX; Zhou YF; Zhang YP; Yuan YZ
Inflammation; 2012 Jun; 35(3):1023-30. PubMed ID: 22213034
[TBL] [Abstract][Full Text] [Related]
10. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
11. Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease.
Sans M; Danese S; de la Motte C; de Souza HS; Rivera-Reyes BM; West GA; Phillips M; Katz JA; Fiocchi C
Gastroenterology; 2007 Jan; 132(1):139-53. PubMed ID: 17241867
[TBL] [Abstract][Full Text] [Related]
12. Fractalkine is expressed in early and advanced atherosclerotic lesions and supports monocyte recruitment via CX3CR1.
Stolla M; Pelisek J; von Brühl ML; Schäfer A; Barocke V; Heider P; Lorenz M; Tirniceriu A; Steinhart A; Bauersachs J; Bray PF; Massberg S; Schulz C
PLoS One; 2012; 7(8):e43572. PubMed ID: 22916279
[TBL] [Abstract][Full Text] [Related]
13. Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.
Chen X; He X; Xu F; Xu N; Sharifi NH; Zhang P; Flores JJ; Wu L; He Q; Kanamaru H; Zhu S; Dong S; Han M; Yuan Y; Huang L; Miao L; Zhang JH; Zhou Y; Tang J
Stroke; 2023 Sep; 54(9):2420-2433. PubMed ID: 37465997
[TBL] [Abstract][Full Text] [Related]
14. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
15. Role of Fractalkine-CX3CR1 Axis in Acute Rejection of Mouse Heart Allografts Subjected to Ischemia Reperfusion Injury.
Kanzawa T; Tokita D; Saiga K; Yamakawa T; Ishigooka H; Fukuda H; Katsumata H; Miyairi S; Ishii R; Hirai T; Imai T; Okumi M; Tanabe K
Transpl Int; 2022; 35():10157. PubMed ID: 35185378
[TBL] [Abstract][Full Text] [Related]
16. Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.
Jiang M; Xie H; Zhang C; Wang T; Tian H; Lu L; Xu JY; Xu GT; Liu L; Zhang J
J Cell Mol Med; 2022 Feb; 26(4):1229-1244. PubMed ID: 35023309
[TBL] [Abstract][Full Text] [Related]
17. Fractalkine/CX3CR1 signalling in chronic pain and inflammation.
Clark AK; Staniland AA; Malcangio M
Curr Pharm Biotechnol; 2011 Oct; 12(10):1707-14. PubMed ID: 21466443
[TBL] [Abstract][Full Text] [Related]
18. NF-κB-mediated inverse regulation of fractalkine and CX3CR1 during CLP-induced sepsis.
Raspé C; Höcherl K; Rath S; Sauvant C; Bucher M
Cytokine; 2013 Jan; 61(1):97-103. PubMed ID: 23026294
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species mediate high glucose-induced plasminogen activator inhibitor-1 up-regulation in mesangial cells and in diabetic kidney.
Lee EA; Seo JY; Jiang Z; Yu MR; Kwon MK; Ha H; Lee HB
Kidney Int; 2005 May; 67(5):1762-71. PubMed ID: 15840023
[TBL] [Abstract][Full Text] [Related]
20. Disruption of Fractalkine Signaling Leads to Microglial Activation and Neuronal Damage in the Diabetic Retina.
Cardona SM; Mendiola AS; Yang YC; Adkins SL; Torres V; Cardona AE
ASN Neuro; 2015; 7(5):. PubMed ID: 26514658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
